Expression of selected tumor suppressor and oncogenes in endometrium of women with endometriosis
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: It is becoming increasingly evident that the eutopic endometrium of women with endometriosis shows certain genetic alterations which are not found in the endometrium of disease-free women. The aim of the study was to compare the expression level of mammalian target of rapamycin (mTOR) tumor suppressor and oncogene-related genes in the endometrium of women with and without endometriosis as well as in ovarian endometriosis. METHODS: A total of 81 regularly menstruating patients were recruited in the study. We applied the micro fluidic gene array to examine the expression of 15 human tumor suppressor and oncogenes in eutopic endometrium of 40 women with endometriosis and 41 controls without endometriosis. In 14 patients with endometriosis, gene expression was also studied in matched ovarian lesions. We studied the following genes: NF1, RHEB, mTOR, PTEN, TSC1, TSC2, KRAS, S6K1, TP53, EIF4E, LKB1, PIK3CA, BECN1, 4EBP1 and AKT1. Immunohistochemical studies were subsequently performed for selected proteins. RESULTS: Of the 15 studied genes, we found significantly higher levels of oncogene AKT1 (P = 0.006) and tumor suppressor gene 4EBP1 (P = 0.01) mRNAs in the eutopic endometrium of women with endometriosis compared with control patients. Immunohistochemistry showed that 4EBP1 and AKT1 proteins were expressed in eutopic endometrium. CONCLUSIONS: Our results suggest that up-regulation of AKT1 and 4EBP1 in eutopic endometrium may be associated with the pathogenesis of endometriosis, but their precise role remains to be established.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Revised American Society for Reproductive Medicine classification of endometriosis: 1996
American Society for Reproductive Medicine (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81391-x · Cited by 3,018
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Shaw, R. J., & Cantley, L. C. (2006) · Nature · doi:10.1038/nature04869 · Cited by 2,019 · cited 2×
“In addition to its role in promoting protein synthesis, S6K1 represses the phosphatidylinositol 3-kinase (PI3K) related pathways, whereas different growth factors, mitogens and hormones activate PI3K signaling and consequently mTOR (Shaw and Cantley, 2006).”
BackgroundmTOR and cancer: insights into a complex relationship
Sabatini, D. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1974 · Cited by 1,322 · cited 12×
“It is also difficult to comment on the correlation between expression of some genes, for example P53 and PTEN, and cycle day as we limited our patients to only 5 days of the proliferative phase (day 8–12), the time when a great majority of patients are operated on in our Department.”
BackgroundInfluentialHeterotopic or misplaced endometrial tissue
Sampson, J. A. (1925) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(25)90629-1 · Cited by 229 · cited 1×
“The most widely accepted theory stipulates that during menstruation there is a reflux of endometrial tissue via the fallopian tubes into the peritoneal cavity where it can implant (Sampson, 1925).”
Background
Cited by
Endometrial alterations in endometriosis: a systematic review of putative biomarkers
May, K. E., Villar, J., Kirtley, S., Kennedy, S. H., & Becker, C. M. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr013 · Cited by 237
Eutopic endometrium in women with endometriosis: ground zero for the study of implantation defects
Lessey, B., Lebovic, D., & Taylor, R. (2013) · Seminars in Reproductive Medicine · doi:10.1055/s-0032-1333476 · Cited by 113
Dawson, A., Llauradó Fernandez, M., Anglesio, M., Yong, P. J., & Carey, M. S. (2018) · ecancermedicalscience · doi:10.3332/ecancer.2018.803 · Cited by 106
“Yamamoto S, Tsuda H, and Takano M, et al (2012) Loss of ARID1A protein expression occurs as an early event in ovarian clearcell carcinoma development and frequently coexists with PIK3CA mutations Mod Pathol 25(4) 615–624 https://doi.org/10.1038/ modpathol.2011.189 117.”
BackgroundInfluentialLaudanski, P., Charkiewicz, R., Kuzmicki, M., Szamatowicz, J., Charkiewicz, A., & Niklinski, J. (2013) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-11-78 · Cited by 70
Self-citationLaudanski, P., Charkiewicz, R., Tolwinska, A., Szamatowicz, J., Charkiewicz, A., & Niklinski, J. (2015) · BioMed Research International · doi:10.1155/2015/760698 · Cited by 48
Self-citation
Metadata
- Authors
- Laudanski, P., Szamatowicz, J., Kowalczuk, O., Kuzmicki, M., Grabowicz, M., & Chyczewski, L.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-05-08
- Volume
- 24
- Issue
- 8
- Pages
- 1880-1890
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2122998411
- Cited by
- 66
- References
- 5
- FWCI
- 4.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Expression of selected tumor suppressor and oncogenes in endometrium of women with endometriosis. https://app.cochat.ai/papers/10.1093/humrep/dep175
- The paper
- Laudanski, P., Szamatowicz, J., Kowalczuk, O., Kuzmicki, M., Grabowicz, M., & Chyczewski, L. (2009). Expression of selected tumor suppressor and oncogenes in endometrium of women with endometriosis. Human Reproduction. https://doi.org/10.1093/humrep/dep175
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.